"Enhanced" DNA Witness:
10/12/2006
DNAPrint Genomics To Exhibit Enhanced DNAWitness™ With Retinome™ 2.0 At International Convention Of Police Chiefs
SARASOTA, Fla. – DNAPrint Genomics, Inc. (OTCBB: DNAG) today announced that the Company will exhibit its products, including DNAWitness™ with Retinome™ 2.0, at the 113th Annual International Association of Chiefs of Police (IACP) Conference in Booth 803 at the Boston Exhibition and Convention Center in Boston, Mass., from Sunday, Oct. 15 through Tuesday, Oct. 17.
“We are extremely pleased to be exhibiting DNAWitness™ and other products at the IACP Conference, which draws 14,000 law enforcement officials from all over the world,” stated DNAPrint President and Chief Executive Officer Richard Gabriel. “We look forward to demonstrating how DNAWitness™ can improve their crime scene investigations and enhance their forensic capabilties.”
DNAWitness™ employs patent-pending, database-driven methods to infer elements of physical appearance from crime scene DNA and allow forensic investigators to “paint” molecular portraits of a suspect. This innovative forensic technology has already been used in some 130 cases, including the arrest and conviction of Derrick Todd Lee for a series of murders in Louisiana and in New Scotland Yard’s search for the so-called Minstead Rapist, a serial sex offender who is operating in an area south of London.
DNAWitness™ derives the percentage of European, East Asian, Native American, and Sub- Saharan African markers in a person’s DNA. This ratio for an individual is termed Bio- Geographical Ancestry (BGA), representing general characteristics that can be matched with a searchable database containing information and photographs collected from samples around the world, leading to more accurate identifications of potential of criminalsuspects.
Retinome™ 2.0 can be combined with the DNAWitness™ product to determine a person’s eye color. The Company’s patent-pending technology identifies additional markers covering newly identified and informative regions of the human pigmentation gene OCA2. The Company has also developed a Retinome 2.0 capillary electrophoresis kit, which permits investigators to test Retinome 2.0 in their own laboratories, obviating the need to ship their samples to DNAPrint (though that option is still available).
DNAPrint will also be exhibiting its tests for mitochondrial and Y DNA trace samples or mixtures.
Ann
